[1] Wei Yadong, Chen Tao, Yu Tao, et al. Cao Liping’s Clinical Experience of Treating Non-Small-Cell Lung Cancer by Qingjin Guben Decoction [J]. Modern Traditional Chinese Medicine, 2017, (05): 1-3. [doi: 10.13424/j.cnki.mtcm.2017.05.001]
Cao Liping’s Clinical Experience of Treating Non-Small-Cell Lung Cancer by Qingjin Guben Decoction
Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN]
Volumes & Issues:
2017 05
pagination:
1-3
Column:
Publication date:
2017-09-10
- Article number:
- 1672-0571(2017)05-0001-03
- ZTFLH:
- R246.5
- Code:
- A
- Abstract:
- In recent years,the incidence and case fatality rate of non-small-cell lung cancer(NSCLC) are rapidly increasing and the pathogenesisis believed to be lung and spleen qi deficiency,intermin-gled phlegm and blood stasis as well as endogenous pathogenic toxin.The treatment attaches great importance to clearing lung heat,resolving phlegm-dampness and invigorating spleen and supplementing qi.Cao Liping,a chief physician, through his clinical researches on patients condition after NSCL Coperation,radio therapy and chemotherapyas well as targeted therapy,put forward an effective decoction—Qingjin Guben decoction for lung-heat and phlegm-damp NSCLC.It can effectively improve patients quality of life and prolong the survival period.
References:
[1]林燕, 段春燕, 陆明.中医治疗对于中晚期非小细胞肺癌的临床意义分析[J].时珍国医国药, 2013, 24 (4) :896-897.
[2]何立丽, 顾恪波.半夏提取物抗恶性肿瘤的作用机制[J].中华中医药杂志, 2017, 32 (2) :685-686.
[3]苏芳, 于常华.薏苡仁油抗恶性肿瘤作用的研究进展[J].临床荟萃, 2014, 29 (9) :1075-1076.
[4]苗文红, 谢燕华, 李耀辉, 等.曹利平应用加味清金化痰汤治疗肺癌经验[J].陕西中医, 2014, 35 (3) :212-213.
[5]苗文红, 谢燕华, 李耀辉, 等.曹利平主任医师辨治肿瘤思路及经验[J].陕西中医, 2014, 35 (8) :1045-1047.
[6]王保芹, 李泽庚.肺癌中医辨证分型研究进展[J].陕西中医药大学学报, 2016, 39 (4) :99-102.
Memo
收稿日期：2017-04-06作者简介：陈国庆(1954-),男,主任医师,主要从事心血管疾病临床、科研工作。E-mail:huxicaoliping@163.com;
基金项目:曹利平全国名老中医药专家传承工作室[财社(2013)135号];
Last Update:
2017-09-15